Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zi Xiu Tang is marketed as a bee pollen dietary supplement for weight loss. FDA laboratory analysis has confirmed that it contains hidden drug ingredients including sibutramine (a controlled substance removed from the market in 2010 due to safety concerns), phenolphthalein (a chemical not approved as an active ingredient in any US drug and a potential carcinogen), and fluoxetine (an SSRI antidepressant). These undeclared ingredients pose significant health risks, including increased blood pressure, heart rate, and potential for life-threatening interactions with other medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zi xiu tang bee pollen.